Taurodeoxycholic acid

Taurodeoxycholic acid is a lipid of Sterol Lipids (ST) class. Taurodeoxycholic acid is associated with abnormalities such as Ischemia and Wiskott-Aldrich Syndrome. The involved functions are known as Cell Proliferation, Transcriptional Activation, Phosphorylation, Anabolism and Biochemical Pathway. Taurodeoxycholic acid often locates in Body tissue, Epithelium, Blood, Mucous Membrane and Hepatic. The associated genes with Taurodeoxycholic acid are NOX5 gene, GPBAR1 gene, NR1H4 gene and SLC33A1 gene. The related lipids are cholanic acid, taurolithocholic acid 3-sulfate, Sterols, 7-dehydrocholesterol and tauromuricholic acid.

Cross Reference

Introduction

To understand associated biological information of Taurodeoxycholic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Taurodeoxycholic acid?

Taurodeoxycholic acid is suspected in Ischemia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Taurodeoxycholic acid

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Birth Weight D001724 23 associated lipids
Body Weight D001835 333 associated lipids
Cholestasis D002779 23 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Fetal Resorption D005327 15 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Per page 10 20 | Total 13

PubChem Associated disorders and diseases

What pathways are associated with Taurodeoxycholic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Taurodeoxycholic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Taurodeoxycholic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Taurodeoxycholic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Taurodeoxycholic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Taurodeoxycholic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Taurodeoxycholic acid

Download all related citations
Per page 10 20 50 100 | Total 449
Authors Title Published Journal PubMed Link
Jacewicz D et al. A novel biosensor for evaluation of apoptotic or necrotic effects of nitrogen dioxide during acute pancreatitis in rat. 2010 Sensors (Basel) pmid:22315540
Parmentier G and Eyssen H Synthesis and characteristics of the specific monosulfates of chenodeoxycholate, deoxycholate and their taurine or glycine conjugates. 1977 Steroids pmid:611627
Song C et al. Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. 2000 Steroids pmid:10936612
Roslyn JJ et al. Regulation of gallbladder ion transport: role of biliary lipids. 1989 Surgery pmid:2916181
Lillemoe KD et al. Taurodeoxycholate modulates the effects of pepsin and trypsin in experimental esophagitis. 1985 Surgery pmid:3923639
Yamaguchi J et al. Taurodeoxycholate increases intestinal epithelial cell proliferation through c-myc expression. 2004 Surgery pmid:14739857
Zahiri HR et al. Bile salt supplementation acts via the farnesoid X receptor to alleviate lipopolysaccharide-induced intestinal injury. 2011 Surgery pmid:21878234
Jin HT et al. A polyamine analog bismethylspermine ameliorates severe pancreatitis induced by intraductal infusion of taurodeoxycholate. 2008 Surgery pmid:18571584
Lillemoe KD et al. Role of the components of the gastroduodenal contents in experimental acid esophagitis. 1982 Surgery pmid:6808683
Alvarez C et al. The pancreatic duct epithelium in vitro: bile acid injury and the effect of epidermal growth factor. 1997 Surgery pmid:9288155